Myostatin: genetic variants, therapy and gene doping

Since its discovery, myostatin (MSTN) has been at the forefront of muscle therapy research because intrinsic mutations or inhibition of this protein, by either pharmacological or genetic means, result in muscle hypertrophy and hyperplasia. In addition to muscle growth, MSTN inhibition potentially disturbs connective tissue, leads to strength modulation, facilitates myoblast transplantation, promotes tissue regeneration, induces adipose tissue thermogenesis and increases muscle oxidative phenotype. It is also known that current advances in gene therapy have an impact on sports because of the illicit use of such methods. However, the adverse effects of these methods, their impact on athletic performance in humans and the means of detecting gene doping are as yet unknown. The aim of the present review is to discuss biosynthesis, genetic variants, pharmacological/genetic manipulation, doping and athletic performance in relation to the MSTN pathway. As will be concluded from the manuscript, MSTN emerges as a promising molecule for combating muscle wasting diseases and for triggering wide-ranging discussion in view of its possible use in gene doping.

• Publication year

  2012

• Venue

  Brazilian Journal of Pharmaceutical Sciences

• Publication date

  2012-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1590/S1984-82502012000300003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene Therapy for Heart Failure

  2012cited by this paper
• A Novel Therapeutic Approach to Treating Obesity through Modulation of TGFβ Signaling

  2012cited by this paper
• In vivo gene delivery by nonviral vectors: overcoming hurdles?

  2012cited by this paper
• RNA therapeutics: beyond RNA interference and antisense oligonucleotides

  2012cited by this paper
• Alternative options for DNA-based experimental therapy of β-thalassemia

  2012cited by this paper
• Characterisation of connective tissue from the hypertrophic skeletal muscle of myostatin null mice

  2012cited by this paper
• Exercise training attenuates the hypermuscular phenotype and restores skeletal muscle function in the myostatin null mouse

  2012cited by this paper
• Ex vivo gene therapy and vision.

  2012cited by this paper
• Blockade of the Activin Receptor IIB Activates Functional Brown Adipogenesis and Thermogenesis by Inducing Mitochondrial Oxidative Metabolism

  2012cited by this paper
• Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation

  2012cited by this paper
• Sarcopenia

  2011cited by this paper
• Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance

  2011cited by this paper
• Treating cancer cachexia to treat cancer

  2011cited by this paper
• A polymerase chain reaction-based methodology to detect gene doping

  2011cited by this paper
• Effect of postdevelopmental myostatin depletion on myofibrillar protein metabolism.

  2011cited by this paper
• The K153R Polymorphism in the Myostatin Gene and Muscle Power Phenotypes in Young, Non-Athletic Men

  2011cited by this paper
• Long-Term Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Golden Retriever Muscular Dystrophy

  2011cited by this paper
• The use of genes for performance enhancement: doping or therapy?

  2011cited by this paper
• Targeting the myostatin signaling pathway to treat muscle wasting diseases

  2011cited by this paper
• Short communication: influence of the muscle hypertrophy mutation of the myostatin gene on milk production traits and milk fatty acid composition in dual-purpose Belgian Blue dairy cattle.

  2011cited by this paper
• Human myostatin negatively regulates human myoblast growth and differentiation.

  2011cited by this paper
• Simultaneous detection of transgenic DNA by surface plasmon resonance imaging with potential application to gene doping detection.

  2011cited by this paper
• Transgene traceability in transgenic mice: a bioanalytical approach for potential gene-doping analysis.

  2011cited by this paper
• Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor.

  2011cited by this paper
• Antisense-induced Myostatin Exon Skipping Leads to Muscle Hypertrophy in Mice Following Octa guanidine Morpholino Oligomer Treatment.

  2011cited by this paper
• RNA interference for performance enhancement and detection in doping control.

  2011cited by this paper
• Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice

  2010cited by this paper
• Antibody‐directed myostatin inhibition in 21‐mo‐old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function

  2010cited by this paper
• Genetic Deletion of Myostatin From the Heart Prevents Skeletal Muscle Atrophy in Heart Failure

  2010cited by this paper
• Regulation of muscle mass by follistatin and activins.

  2010cited by this paper
• Extracellular Regulation of Myostatin: A Molecular Rheostat for Muscle Mass.

  2010cited by this paper
• Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type.

  2010cited by this paper
• Gene doping: the hype and the harm.

  2010cited by this paper
• Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training

  2010cited by this paper
• A Sequence Polymorphism in MSTN Predicts Sprinting Ability and Racing Stamina in Thoroughbred Horses

  2010cited by this paper
• The hunt for gene dopers.

  2009cited by this paper
• Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates

  2009cited by this paper
• Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin.

  2009cited by this paper
• Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO‐029

  2009cited by this paper
• Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice

  2009cited by this paper
• Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease

  2009cited by this paper
• Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors

  2008cited by this paper
• A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy

  2008cited by this paper
• A Mutation in the Myostatin Gene Increases Muscle Mass and Enhances Racing Performance in Heterozygote Dogs

  2007cited by this paper
• Potential use of gene transfer in athletic performance enhancement.

  2007cited by this paper
• Gene doping: a review of performance-enhancing genetics.

  2007cited by this paper
• Gene therapy for severe combined immunodeficiency.

  2005cited by this paper
• Regulation of muscle growth by multiple ligands signaling through activin type II receptors.

  2005cited by this paper
• Myostatin gene silenced by RNAi show a zebrafish giant phenotype.

  2005cited by this paper
• Myostatin mutation associated with gross muscle hypertrophy in a child.

  2004influential reference
• Myostatin negatively regulates satellite cell activation and self-renewal

  2003cited by this paper
• Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.

  2003cited by this paper
• Functional improvement of dystrophic muscle by myostatin blockade

  2002cited by this paper
• Induction of Cachexia in Mice by Systemically Administered Myostatin

  2002cited by this paper
• Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member

  1997cited by this paper
• Double muscling in cattle due to mutations in the myostatin gene.

  1997cited by this paper

• Association of Myostatin Gene Polymorphisms with Strength and Muscle Mass in Athletes: A Systematic Review and Meta-Analysis of the MSTN rs1805086 Mutation

  2022cites this paper
• Genetic variations in the Myostatin gene affecting growth traits in sheep

  2021cites this paper
• МЕТААНАЛИЗ АССОЦИАЦИИ ПОЛИМОРФИЗМА ГЕНА MSTN RS1805086 С СИЛОВЫМИ ПОКАЗАТЕЛЯМИ СПОРТСМЕНОВ

  2021cites this paper
• Doping

  2019cites this paper
• Is Enhancement the Price of Prevention in Human Gene Editing?

  2018cites this paper
• GENETICS IN MODERN SPORTS: SCIENTIFIC TECHNOLOGIES FOR NEW ACHIEVEMENTS

  2018cites this paper
• Equine performance genes and the future of doping in horseracing.

  2017cites this paper
• Morphometric Study of Muscle Fibers in Rats Submitted to Strength Training and Growth Hormone

  2017cites this paper
• Supplement with Cystoseira canariensis promotes an increase of resistance to the maximum load in the grastrocnemius muscle of female rats

  2014cites this paper
• BIOMOTRICITY ROUNDTABLE-GENÔMICA E FISIOLOGIA MOLECULAR DO EXERCÍCIO E DO ESPORTE

  2013cites this paper